Centrum gets travel foucus
This article was originally published in OTC Bulletin & The Rose Sheet
Pfizer Consumer Healthcare is urging Germans to prepare their body for the upcoming travel season with three Centrum Fokus supplement products designed to tackle common travel health issues.
You may also be interested in...
Verona Pharma’s candidate COPD therapy ensifentrine has a first-in-class dual mechanism of action and is to be explored as an add-on to LAMA and LABA therapy in two Phase III clinical studies.
No device-related warning letters were released by the US FDA the week of 2 June.
The Minnesota-based medtech giant has had to yank a software used on its SealthStation platforms used to help surgeons navigate a patient’s brain during surgery. However, minor movements by the patient have been found to give false imaging that could endanger the patient’s life.